
Opinion|Videos|October 31, 2024 (Updated: October 31, 2024)
Evaluating Treatment Failure and Symptomatic Remission in MDD
Experts in the management of mood disorders discuss the challenges of treatment failure and achieving symptomatic remission in MDD. They examine the efficacy of antidepressant and rapid-acting treatments, offering insights into evaluating and enhancing treatment outcomes.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Postmodern Worldview and Contemporary Psychiatry
2
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
3
DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD
4
New Phase 3 Data on Oveporexton for Narcolepsy Type 1
5








